Research European Commission Life Sciences and Biotechnology A Strategy for Europe Christian Patermann

Research European Commission TRENDS OF LIFE SCIENCES AND BIOTECHNOLOGY at the beginning of the years 2000 An explosion of knowledge l Large international genome sequencing programmes e.g. yeast 1996; Arabidopsis 2000; Listeria 2000; human 2001 l Bioinformatics: emergence of a new research field l From biosensors to nanobiotechnologies A wide range of applications * Gene therapies * Preventive medicine to encourage healthy ageing * Reappraisal of food production systems * Sustainable production of added value molecules * Monitoring biodiversity and ecosystem dynamics

Research European Commission  Lisbon Summit - March 2000 Sets a strategic goal for Europe to become the most competitive and dynamic knowledge-based economy in the world  Stockholm Summit - March 2001 Highlights the importance of research, entrepreneurship... Identifies biotechnology as a frontier technology … and requests the Commission, together with the Council, to examine measures required to utilise the full potential of biotechnology and strengthen the European biotechnology sector's competitiveness THE POLITICAL DRIVE

Research European Commission Life Sciences and Biotechnology - A Strategy for Europe COM(2002) January 2002 Life Sciences and Biotechnology - A Strategy for Europe COM(2002) January 2002

Research European Commission Life Sciences and Biotechnology - A Strategy for Europe  How can Europe best attract the human, industrial and financial resources to develop and apply these technologies to meet society’s needs and increase its competitiveness?  How can Europe deliver effective, credible and responsible policies, which ensure the confidence and support of its citizens?  How can Europe best respond to the global challenges, develop its domestic policies with a clear international perspective and act internationally to pursue its interests?

Research European Commission A European Strategy for Life Sciences and Biotechnology: The Action Plan HARVESTING the POTENTIAL 1 GOVERNING Life Sciences and Biotechnology2 3 RESPONDING to GLOBAL challenges 4 Implementation and COHERENCE across policies, sectors and actors Who? How? EC + EP + COUNCIL + MEMBER STATES + REGIONS + PRIVATE SECTOR + ACADEMIA + PROFESSIONAL ASSOCIATIONS + CIVIL SOCIETY + EIB + EFSA + EMEA + EGE...

Research European Commission A European Strategy for Life Sciences and Biotechnology : The Action Plan - 30 Actions in 4 blocks 1. Harvesting the Potential * * The resource Base  investing in people  generating and exploiting knowledge  intellectual property protection  capital base * * Networking Europe’s Biotechnology Communities * * A pro-active role for public authorities 2. Governing Life Sciences and Biotechnology * * Societal scrutiny and dialogue * * Developing Life Sciences and Biotechnology in harmony with ethical values and social goals * * Demand-driven applications through informed choice * * Confidence in science-based regulatory oversight 3. Responding to global challenge * A European agenda for international collaboration * Europe’s responsibilities towards the developing world 4. Implementation and coherence across policies, sectors and actors

Research European Commission Life Sciences and Biotechnology Action Plan GOVERNING Life Sciences & Biotech - - Societal scrutiny and dialogue - Ethical values and societal goals - Informed choice, demand-driven applications - Science-based regulatory oversight - Basic regulatory principlesGOVERNING Life Sciences & Biotech - - Societal scrutiny and dialogue - Ethical values and societal goals - Informed choice, demand-driven applications - Science-based regulatory oversight - Basic regulatory principles

Research European Commission : SOCIETAL SCRUTINY and DIALOGUE Life Sciences and Biotechnology Strategy Action 13 : SOCIETAL SCRUTINY and DIALOGUE CHALLENGES public understanding  Enhance public understanding of life sciences and biotechnology awareness of public perceptions and awareness of public perceptions on life science and biotechnology societal- involvement  Facilitate broad- and societal- involvement in life sciences and biotechnology participative governance  Build towards a participative governance model for life sciences and biotechnology

Research European Commission ACTIONS  Facilitate the public understanding of science  Improve and facilitate the science communication process, with the involvement of the media  Monitor public perception  Encourage civil society involvement (networks of citizens)  Facilitate the exchange of information and opinions among stakeholders, science operators, policy makers and civil society  MULTISTAKEHOLDERS FORA for DEBATES on life sciences and biotechnology - INCLUSIVE of all stakeholders - well INFORMED and COMPREHENSIVE - MUTUALLY INFORMATIVE - transparent and mutually RESPECTFUL  MULTISTAKEHOLDERS FORA for DEBATES on life sciences and biotechnology - INCLUSIVE of all stakeholders - well INFORMED and COMPREHENSIVE - MUTUALLY INFORMATIVE - transparent and mutually RESPECTFUL : SOCIETAL SCRUTINY and DIALOGUE Life Sciences and Biotechnology Strategy Action 13 : SOCIETAL SCRUTINY and DIALOGUE

Research European Commission The European Group on Life Sciences Established by Commissioner P. Busquin in April 2000, with the mandate of: providing high level advice on the current situation and foreseeable developments in the field of life sciences supporting broad science-communication strategies, particularly by organising a Life Sciences Discussion Platform Members 2002 Members 2002 : V. De Lorenzo (E) (Chair), D. Burke (UK), P. Cunningham (IRL), L. Kovac (SK), P. Kourilsky (F), C. Nüsslein-Volhard (D), A. Mc Laren (UK), N Rosentahl (USA- I), J. van Bemmel (NL), M. van Montagu (B), L. Santi (I), H. Wigzell (S), E-L Winnacker (D)

Research European Commission LIFE SCIENCES DISCUSSION PLATFORMS SCIENTISTS, INDUSTRY, CIVIL SOCIETY, YOUTH, INTEREST GROUPS, MEDIA, POLICY MAKERS... * Multiple Stakeholders * Reciprocal Information * Questions, Debate

Research European Commission CHALLENGES u To develop life sciences and biotechnology in a responsible manner: in harmony with ethical values and societal goals, while respecting cultural pluralism. Harmony with ethical values and societal goals Life Sciences and Biotechnology Strategy Action 14 : Harmony with ethical values and societal goals ACTIONS *Research into socio-economic and ethical issues and development of assessment criteria. *Integration of ethical, social and legal aspects in EC funded research. *Monitoring ethical debate and legal framework *Attempt consensus on ethical guidelines. *Networking of national and local ethics committeesACTIONS *Research into socio-economic and ethical issues and development of assessment criteria. *Integration of ethical, social and legal aspects in EC funded research. *Monitoring ethical debate and legal framework *Attempt consensus on ethical guidelines. *Networking of national and local ethics committees Topics: Xenotransplantation, Human embryonic stem cells, Biobanks, Genetic testing Topics: Xenotransplantation, Human embryonic stem cells, Biobanks, Genetic testing

Research European Commission MOBILISATION OF ALL ACTORS SUCCESS will depend on MOBILISATION OF ALL ACTORS Ethical Bodies Parliament CommissionMember States Regions European Investment Bank Private Sector Academia Civil Society RESEARCHDEVELOPMENTREGULATION DELIVERABLES FOR SOCIETY

Research European Commission For more information